CISD3
gene geneOn this page
Also known as Miner2MiNT
Summary
CISD3 (CDGSH iron sulfur domain 3, HGNC:27578) is a protein-coding gene on chromosome 17q12, encoding CDGSH iron-sulfur domain-containing protein 3, mitochondrial (P0C7P0). Can transfer its iron-sulfur clusters to the apoferrodoxins FDX1 and FDX2.
CISD3 is a member of the CDGSH domain-containing family, which may play a role in regulating electron transport and oxidative phosphorylation (Wiley et al., 2007 [PubMed 17376863]).
Source: NCBI Gene 284106 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 130 total
- MANE Select transcript:
NM_001136498
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27578 |
| Approved symbol | CISD3 |
| Name | CDGSH iron sulfur domain 3 |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Miner2, MiNT |
| Ensembl gene | ENSG00000277972 |
| Ensembl biotype | protein_coding |
| OMIM | 611933 |
| Entrez | 284106 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 5 protein_coding, 2 retained_intron
ENST00000613478, ENST00000616128, ENST00000619858, ENST00000894448, ENST00000894449, ENST00000894450, ENST00000939173
RefSeq mRNA: 1 — MANE Select: NM_001136498
NM_001136498
CCDS: CCDS45662
Canonical transcript exons
ENST00000613478 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003732535 | 38731320 | 38731439 |
| ENSE00003736893 | 38733276 | 38735605 |
| ENSE00003740030 | 38730760 | 38730795 |
| ENSE00003749580 | 38730341 | 38730406 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 97.74.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.2557 / max 82.9579, expressed in 1797 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 160516 | 11.0184 | 1778 |
| 160515 | 1.2373 | 882 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 97.74 | gold quality |
| apex of heart | UBERON:0002098 | 97.11 | gold quality |
| right lobe of liver | UBERON:0001114 | 97.06 | gold quality |
| liver | UBERON:0002107 | 95.80 | gold quality |
| body of pancreas | UBERON:0001150 | 95.49 | gold quality |
| duodenum | UBERON:0002114 | 95.30 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.21 | gold quality |
| transverse colon | UBERON:0001157 | 94.28 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 93.80 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.80 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.65 | gold quality |
| right atrium auricular region | UBERON:0006631 | 93.52 | gold quality |
| heart | UBERON:0000948 | 93.49 | gold quality |
| body of stomach | UBERON:0001161 | 93.43 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.30 | gold quality |
| prefrontal cortex | UBERON:0000451 | 92.94 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 92.75 | gold quality |
| small intestine | UBERON:0002108 | 92.62 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 92.62 | gold quality |
| colon | UBERON:0001155 | 92.58 | gold quality |
| fundus of stomach | UBERON:0001160 | 92.42 | gold quality |
| granulocyte | CL:0000094 | 92.31 | gold quality |
| left coronary artery | UBERON:0001626 | 92.20 | gold quality |
| intestine | UBERON:0000160 | 92.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.91 | gold quality |
| pancreas | UBERON:0001264 | 91.80 | gold quality |
| gastrocnemius | UBERON:0001388 | 91.74 | gold quality |
| adrenal gland | UBERON:0002369 | 91.64 | gold quality |
| muscle of leg | UBERON:0001383 | 91.54 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 45.73 |
| E-ANND-3 | yes | 17.65 |
| E-CURD-112 | yes | 13.21 |
| E-MTAB-9543 | yes | 10.01 |
| E-HCAD-13 | yes | 7.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
95 targeting CISD3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-4639-5P | 99.81 | 67.37 | 1028 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-1296-3P | 99.72 | 64.04 | 636 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-6512-3P | 99.65 | 66.07 | 1468 |
| HSA-MIR-6720-5P | 99.65 | 66.22 | 1459 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-1249-5P | 99.61 | 66.55 | 2049 |
| HSA-MIR-6797-5P | 99.61 | 66.55 | 2084 |
Literature-anchored findings (GeneRIF, showing 3)
- Data indicate that mitochondrial inner NEET protein (MiNT)functions within the mitochondria to regulate levels of toxic iron and reactive oxygen species (ROS). (PMID:29259115)
- CISD3 inhibition drives cystine-deprivation induced ferroptosis. (PMID:34497268)
- Biochemical and cellular characterization of the CISD3 protein: Molecular bases of cluster release and destabilizing effects of nitric oxide. (PMID:38354784)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cisd3 | ENSMUSG00000078695 |
| rattus_norvegicus | Cisd3 | ENSRNOG00000036894 |
| drosophila_melanogaster | CG3420 | FBGN0033100 |
| caenorhabditis_elegans | WBGENE00022053 |
Paralogs (2): CISD1 (ENSG00000122873), CISD2 (ENSG00000145354)
Protein
Protein identifiers
CDGSH iron-sulfur domain-containing protein 3, mitochondrial — P0C7P0 (reviewed: P0C7P0)
Alternative names: MitoNEET-related protein 2, Mitochondrial inner NEET protein
All UniProt accessions (1): P0C7P0
UniProt curated annotations — full annotation on UniProt →
Function. Can transfer its iron-sulfur clusters to the apoferrodoxins FDX1 and FDX2. Contributes to mitochondrial iron homeostasis and in maintaining normal levels of free iron and reactive oxygen species, and thereby contributes to normal mitochondrial function.
Subunit / interactions. Monomer.
Subcellular location. Mitochondrion.
Cofactor. Binds 2 [2Fe-2S] clusters per subunit.
Similarity. Belongs to the CISD protein family.
RefSeq proteins (1): NP_001129970* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018967 | FeS-contain_CDGSH-typ | Domain |
| IPR042216 | MitoNEET_CISD | Homologous_superfamily |
| IPR052950 | CISD | Family |
Pfam: PF09360
UniProt features (24 total): binding site 8, strand 6, modified residue 3, helix 3, mutagenesis site 2, transit peptide 1, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6AVJ | X-RAY DIFFRACTION | 1.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7P0-F1 | 87.67 | 0.72 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8): 60; 62; 71; 75; 98; 100; 109; 113
Post-translational modifications (3): 55, 55, 86
Mutagenesis-validated functional residues (2):
| Position | Phenotype |
|---|---|
| 75 | increases iron-sulfur cluster stability; when associated with c-113. |
| 113 | increases iron-sulfur cluster stability; when associated with c-75. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 95 (showing top):
GOBP_PROTEIN_MATURATION, GOMF_METAL_CLUSTER_BINDING, GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, VANLOO_SP3_TARGETS_DN, ATF6_TARGET_GENES, BARX1_TARGET_GENES, CREB3L4_TARGET_GENES, DLX6_TARGET_GENES, FOXD2_TARGET_GENES, ID1_TARGET_GENES, ID2_TARGET_GENES, NAB2_TARGET_GENES, SNRNP70_TARGET_GENES, UBN1_TARGET_GENES
GO Biological Process (1): protein maturation (GO:0051604)
GO Molecular Function (3): metal ion binding (GO:0046872), 2 iron, 2 sulfur cluster binding (GO:0051537), iron-sulfur cluster binding (GO:0051536)
GO Cellular Component (3): mitochondrion (GO:0005739), cytoplasm (GO:0005737), intracellular membrane-bounded organelle (GO:0043231)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 2 |
| gene expression | 1 |
| protein metabolic process | 1 |
| cation binding | 1 |
| iron-sulfur cluster binding | 1 |
| metal cluster binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
| membrane-bounded organelle | 1 |
| intracellular organelle | 1 |
Protein interactions and networks
STRING
808 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CISD3 | CISD1 | Q9NZ45 | 991 |
| CISD3 | CISD2 | Q8N5K1 | 962 |
| CISD3 | FDX1 | P10109 | 540 |
| CISD3 | RPL28 | P46779 | 454 |
| CISD3 | CIMAP1C | Q8IXM7 | 453 |
| CISD3 | MNT | Q99583 | 447 |
| CISD3 | HSPB3 | Q12988 | 437 |
| CISD3 | CFTR | P13569 | 424 |
| CISD3 | RPL27A | P46776 | 424 |
| CISD3 | CPEB2 | Q7Z5Q1 | 420 |
| CISD3 | CIAPIN1 | Q6FI81 | 418 |
| CISD3 | ACO1 | P21399 | 404 |
| CISD3 | WFS1 | O76024 | 386 |
| CISD3 | ATXN7L3B | Q96GX2 | 384 |
| CISD3 | DNAJC30 | Q96LL9 | 380 |
IntAct
24 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CHCHD4 | SSNA1 | psi-mi:“MI:0914”(association) | 0.640 |
| LRFN4 | RIMOC1 | psi-mi:“MI:0914”(association) | 0.530 |
| CACNG5 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| HAVCR2 | TCAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| ADAM33 | LRP5 | psi-mi:“MI:0914”(association) | 0.530 |
| PLOD2 | psi-mi:“MI:0914”(association) | 0.530 | |
| NCAPD3 | SMC2 | psi-mi:“MI:0914”(association) | 0.350 |
| SMOC1 | NME2 | psi-mi:“MI:0914”(association) | 0.350 |
| CISD3 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| CISD3 | COQ9 | psi-mi:“MI:0914”(association) | 0.350 |
| CISD3 | TIMM44 | psi-mi:“MI:0914”(association) | 0.350 |
| IGF1R | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| ADAM33 | ADAM10 | psi-mi:“MI:0914”(association) | 0.350 |
| ABCA6 | STX6 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC30A1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC31A1 | DENND11 | psi-mi:“MI:0914”(association) | 0.350 |
| STAT3 | IDH3B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (100): CISD3 (Affinity Capture-MS), CISD3 (Affinity Capture-MS), MIPEP (Affinity Capture-MS), ERAL1 (Affinity Capture-MS), AFG3L2 (Affinity Capture-MS), CLPX (Affinity Capture-MS), GRSF1 (Affinity Capture-MS), SCO2 (Affinity Capture-MS), CLPB (Affinity Capture-MS), PMPCA (Affinity Capture-MS), PMPCB (Affinity Capture-MS), TRMT10C (Affinity Capture-MS), POLRMT (Affinity Capture-MS), CHCHD2 (Affinity Capture-MS), STOML2 (Affinity Capture-MS)
ESM2 similar proteins: A0A1L1SUL6, A4QJJ7, A4QK16, A6H5F6, A6MM34, A6NH52, A6NMK7, A7M939, A8SEA1, A8W3M5, B0Z4S1, B0Z505, B0Z589, B0Z5H3, B1AR13, B1NWE8, B2LMJ1, O19048, O19137, O95639, P0C7P0, P0DI19, P46292, P60335, P83870, P83871, P98138, Q09G48, Q0G9M1, Q0WMV8, Q15365, Q1KXW1, Q332Y0, Q5E9A3, Q5FVR7, Q5R654, Q63789, Q66KE3, Q68S08, Q6DJP7
Diamond homologs: B1AR13, P0C7P0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
130 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 81 |
| Likely benign | 32 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
499 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:38735596:CCGTT:C | acceptor_gain | 1.0000 |
| 17:38735597:CGTT:C | acceptor_gain | 1.0000 |
| 17:38735597:CGTTC:C | acceptor_gain | 1.0000 |
| 17:38735598:GTT:G | acceptor_gain | 1.0000 |
| 17:38735599:TT:T | acceptor_gain | 1.0000 |
| 17:38735601:C:CC | acceptor_gain | 1.0000 |
| 17:38735601:C:CG | acceptor_loss | 1.0000 |
| 17:38735602:T:G | acceptor_loss | 1.0000 |
| 17:38730716:A:AG | acceptor_gain | 0.9900 |
| 17:38730717:A:G | acceptor_gain | 0.9900 |
| 17:38731843:G:GG | donor_gain | 0.9900 |
| 17:38731311:T:TA | acceptor_gain | 0.9800 |
| 17:38731435:AGCAG:A | donor_loss | 0.9800 |
| 17:38731436:GCAGG:G | donor_loss | 0.9800 |
| 17:38731437:CAGGT:C | donor_loss | 0.9800 |
| 17:38731438:AG:A | donor_loss | 0.9800 |
| 17:38731439:GGTGA:G | donor_loss | 0.9800 |
| 17:38731440:G:A | donor_loss | 0.9800 |
| 17:38731441:TGAGA:T | donor_loss | 0.9800 |
| 17:38731906:G:GA | donor_gain | 0.9800 |
| 17:38730403:CCGGG:C | donor_loss | 0.9700 |
| 17:38730404:CGGGT:C | donor_loss | 0.9700 |
| 17:38730405:GGGTG:G | donor_loss | 0.9700 |
| 17:38730406:GGT:G | donor_loss | 0.9700 |
| 17:38730407:G:C | donor_loss | 0.9700 |
| 17:38730408:T:A | donor_loss | 0.9700 |
| 17:38730409:GAGCA:G | donor_loss | 0.9700 |
| 17:38731411:G:GA | donor_gain | 0.9700 |
| 17:38731442:GAGAC:G | donor_loss | 0.9700 |
| 17:38731883:A:G | donor_gain | 0.9700 |
AlphaMissense
812 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:38733374:G:C | K101N | 0.990 |
| 17:38733374:G:T | K101N | 0.990 |
| 17:38731412:G:C | W59C | 0.989 |
| 17:38731412:G:T | W59C | 0.989 |
| 17:38733331:T:C | F87S | 0.988 |
| 17:38731423:G:T | G63V | 0.985 |
| 17:38731429:G:T | S65I | 0.985 |
| 17:38733283:G:A | C71Y | 0.985 |
| 17:38731423:G:A | G63D | 0.984 |
| 17:38733330:T:C | F87L | 0.983 |
| 17:38733332:C:A | F87L | 0.983 |
| 17:38733332:C:G | F87L | 0.983 |
| 17:38731410:T:A | W59R | 0.982 |
| 17:38731410:T:C | W59R | 0.982 |
| 17:38733363:T:C | C98R | 0.982 |
| 17:38733363:T:A | C98S | 0.981 |
| 17:38733364:G:C | C98S | 0.981 |
| 17:38733396:T:A | C109S | 0.981 |
| 17:38733397:G:C | C109S | 0.981 |
| 17:38733282:T:A | C71S | 0.980 |
| 17:38733283:G:C | C71S | 0.980 |
| 17:38731419:T:C | C62R | 0.979 |
| 17:38733282:T:C | C71R | 0.979 |
| 17:38731428:A:C | S65R | 0.978 |
| 17:38731430:C:A | S65R | 0.978 |
| 17:38731430:C:G | S65R | 0.978 |
| 17:38733365:T:G | C98W | 0.978 |
| 17:38733397:G:A | C109Y | 0.978 |
| 17:38731419:T:A | C62S | 0.977 |
| 17:38731420:G:C | C62S | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000215071 (17:38730592 C>G,T), RS1000227757 (17:38731012 G>A), RS1000257530 (17:38731266 C>T), RS1000711107 (17:38730913 G>A), RS1001158702 (17:38732002 C>T), RS1001212193 (17:38732140 T>G), RS1001230984 (17:38732350 T>C), RS1002226020 (17:38733806 T>A), RS1002286801 (17:38733658 G>A), RS1002319370 (17:38734071 C>A,T), RS1003058969 (17:38729418 G>A), RS1003090286 (17:38729652 C>T), RS1003225700 (17:38734750 G>A), RS1003229373 (17:38735369 G>T), RS1003687402 (17:38734916 G>C)
Disease associations
OMIM: gene MIM:611933 | disease phenotypes: MIM:604928, MIM:618371
GenCC curated gene-disease
Mondo (2): Wolfram syndrome 2 (MONDO:0011502), turnpenny-fry syndrome (MONDO:0032707)
Orphanet (2): Wolfram syndrome (Orphanet:3463), Turnpenny-Fry syndrome (Orphanet:688642)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004185_4 | Lung function (FEV1/FVC) | 7.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004713 | FEV/FVC ratio |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C565733 | Wolfram Syndrome 2 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, decreases expression, affects cotreatment, increases abundance | 3 |
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Copper | affects binding, decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Naled | affects expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): turnpenny-fry syndrome, Wolfram syndrome 2